AI assistant
Fluent, Inc. — Director's Dealing 2016
Mar 16, 2016
34456_dirs_2016-03-15_8017a79f-7180-46ff-a8be-b581a37d59f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDI, Inc. (IDI)
CIK: 0001460329
Period of Report: 2016-03-11
Reporting Person: FROST PHILLIP MD ET AL (Director, 10% Owner)
Reporting Person: Frost Gamma Investments Trust (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-11 | Common Stock | A | 900108 | — | Acquired | 12873223 | Indirect |
| 2016-03-11 | Common Stock | C | 524750 | — | Acquired | 13397973 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-11 | Warrant | $ | C | 524750 | Disposed | Common Stock (524750) | Indirect |
Footnotes
F1: The shares of Common Stock were issued as earn-out consideration in connection with that certain Merger Agreement and Plan of Reorganization dated as of December 14, 2014, as amended, to which the Company is a party.
F2: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3: The shares of Common Stock were issued in exchange for the surrender of a warrant to purchase Common Stock, with one share of Common Stock issued for each share of Common Stock available for purchase under such warrant.